Floatz logo

Therapeutic Asset Ratings

228 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Tiselizumab
Follicular Lymphoma
Tianjin Medical University Cancer Institute and HospitalP2CCC (48)
Tislelizumab
HER2 Positive Breast Carcinoma
Tianjin Medical University Cancer Institute and HospitalP2CCC (48)
Tuvonralimab
Non-Small Cell Lung Carcinoma
Tianjin Medical University Cancer Institute and HospitalP2CCC (48)
Adebrelimab
Decitabine
Tianjin Medical University Cancer Institute and HospitalP1/2CCC (48)
Decitabine
Decitabine
Tianjin Medical University Cancer Institute and HospitalP1/2CCC (48)
Decitabine
Adebrelimab (SHR-1316)
Tianjin Medical University Cancer Institute and HospitalP1/2CC (47)
Iparomlimab
Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP2CC (46)
Anti-Cd70-Car-T Cells
Cutaneous T-cell Lymphoma (CTCL)
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
Anti-Cd70-Car-T Cells
NHL (Non-Hodgkin Lymphoma)
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
Anti-Cd70-Car-T Cells
Relapsed / Refractory Solid Tumor
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
cht101
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
cht101
Non-Hodgkin Lymphoma
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
cht101
Relapsed / Refractory Solid Tumor
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
cht102
Malignant Pancreatic Neoplasm
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
Cyclophosphamide
Relapsed / Refractory Solid Tumor
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
Fludarabine
Relapsed / Refractory Solid Tumor
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
Lucar-G39P Cells Product
B-Cell Non-Hodgkin Lymphoma
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
Decitabine
Metastatic Pancreatic Cancer
Tianjin Medical University Cancer Institute and HospitalP1/2CC (43)
Anti-Cd70-Car-T Cells
Peripheral T-cell Lymphoma
Tianjin Medical University Cancer Institute and HospitalP1C (39)
cht101
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Tianjin Medical University Cancer Institute and HospitalP1C (39)
gk01
Neoplasm
Tianjin Medical University Cancer Institute and HospitalP1C (37)
Abesili
Breast Carcinoma
Tianjin Medical University Cancer Institute and HospitalN/AD (30)
Calcium folinate pentahydrate
Acute Leukemia
Tianjin Medical University Cancer Institute and HospitalN/AD (30)
Calcium folinate pentahydrate
Immune-related Adverse Event
Tianjin Medical University Cancer Institute and HospitalN/AD (30)
Calcium folinate pentahydrate
Malignant Solid Tumors
Tianjin Medical University Cancer Institute and HospitalN/AD (30)
Showing 176 to 200 of 228 assets
PreviousPage 8 of 10Next